BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25204645)

  • 1. Influence of B-ring modifications on proton affinity, transmembrane anion transport and anti-cancer properties of synthetic prodigiosenes.
    Marchal E; Rastogi S; Thompson A; Davis JT
    Org Biomol Chem; 2014 Oct; 12(38):7515-22. PubMed ID: 25204645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic prodigiosenes and the influence of C-ring substitution on DNA cleavage, transmembrane chloride transport and basicity.
    Rastogi S; Marchal E; Uddin I; Groves B; Colpitts J; McFarland SA; Davis JT; Thompson A
    Org Biomol Chem; 2013 Jun; 11(23):3834-45. PubMed ID: 23640568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations regarding the utility of prodigiosenes to treat leukemia.
    Smithen DA; Forrester AM; Corkery DP; Dellaire G; Colpitts J; McFarland SA; Berman JN; Thompson A
    Org Biomol Chem; 2013 Jan; 11(1):62-8. PubMed ID: 23070266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-cancer activity of C-ring-functionalized prodigiosin analogues.
    Regourd J; Ali AA; Thompson A
    J Med Chem; 2007 Apr; 50(7):1528-36. PubMed ID: 17348639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodigiosenes conjugated to tamoxifen and estradiol.
    Marchal E; Figliola C; Thompson A
    Org Biomol Chem; 2017 Jun; 15(25):5410-5427. PubMed ID: 28628182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photo-induced anticancer activity and singlet oxygen production of prodigiosenes.
    Savoie H; Figliola C; Marchal E; Crabbe BW; Hallett-Tapley GL; Boyle RW; Thompson A
    Photochem Photobiol Sci; 2018 May; 17(5):599-606. PubMed ID: 29648558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anion transporters and biological systems.
    Gale PA; Pérez-Tomás R; Quesada R
    Acc Chem Res; 2013 Dec; 46(12):2801-13. PubMed ID: 23551251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antimalarial activity of prodigiosenes.
    Marchal E; Smithen DA; Uddin MI; Robertson AW; Jakeman DL; Mollard V; Goodman CD; MacDougall KS; McFarland SA; McFadden GI; Thompson A
    Org Biomol Chem; 2014 Jun; 12(24):4132-42. PubMed ID: 24834447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amido-functionalized prodigiosenes: synthesis and anticancer properties.
    Díaz RI; Bennett SM; Thompson A
    ChemMedChem; 2009 May; 4(5):742-5. PubMed ID: 19350614
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological evaluation of prodigiosene conjugates of porphyrin, estrone and 4-hydroxytamoxifen.
    Hawco CL; Marchal E; Uddin MI; Baker AE; Corkery DP; Dellaire G; Thompson A
    Bioorg Med Chem; 2013 Oct; 21(19):5995-6002. PubMed ID: 23958515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloride anion transport and copper-mediated DNA cleavage by C-ring functionalized prodigiosenes.
    Díaz RI; Regourd J; Santacroce PV; Davis JT; Jakeman DL; Thompson A
    Chem Commun (Camb); 2007 Jul; (26):2701-3. PubMed ID: 17594025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoloprodigiosins from the C-10 bipyrrolic precursor: new antiproliferative prodigiosin analogs.
    Baldino CM; Parr J; Wilson CJ; Ng SC; Yohannes D; Wasserman HH
    Bioorg Med Chem Lett; 2006 Feb; 16(3):701-4. PubMed ID: 16289814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic prodiginine obatoclax (GX15-070) and related analogues: anion binding, transmembrane transport, and cytotoxicity properties.
    Díaz de Greñu B; Iglesias Hernández P; Espona M; Quiñonero D; Light ME; Torroba T; Pérez-Tomás R; Quesada R
    Chemistry; 2011 Dec; 17(50):14074-83. PubMed ID: 22069220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, proton-affinity and anti-cancer properties of the prodigiosin-group natural products.
    Manderville RA
    Curr Med Chem Anticancer Agents; 2001 Aug; 1(2):195-218. PubMed ID: 12678767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the a-ring on the proton affinity and anticancer properties of the prodigiosins.
    Melvin MS; Tomlinson JT; Park G; Day CS; Saluta GR; Kucera GL; Manderville RA
    Chem Res Toxicol; 2002 May; 15(5):734-41. PubMed ID: 12018996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anion-binding properties, and in vitro anticancer activity of prodigiosin analogues.
    Sessler JL; Eller LR; Cho WS; Nicolaou S; Aguilar A; Lee JT; Lynch VM; Magda DJ
    Angew Chem Int Ed Engl; 2005 Sep; 44(37):5989-92. PubMed ID: 16114075
    [No Abstract]   [Full Text] [Related]  

  • 17. Optical properties of prodigiosin and obatoclax: action spectroscopy and theoretical calculations.
    Drink E; Dugourd P; Dumont E; Aronssohn N; Antoine R; Loison C
    Phys Chem Chem Phys; 2015 Oct; 17(39):25946-55. PubMed ID: 26120608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products.
    La JQ; Michaelides AA; Manderville RA
    J Phys Chem B; 2007 Oct; 111(40):11803-11. PubMed ID: 17867672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoinduced cytotoxicity and thioadduct formation by a prodigiosin analogue.
    Tomlinson JT; Park G; Misenheimer JA; Kucera GL; Hesp K; Manderville RA
    Org Lett; 2006 Oct; 8(21):4951-4. PubMed ID: 17020344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perenosins: a new class of anion transporter with anti-cancer activity.
    Van Rossom W; Asby DJ; Tavassoli A; Gale PA
    Org Biomol Chem; 2016 Mar; 14(9):2645-50. PubMed ID: 26905059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.